Pfizer CEO Pens Open Letter on COVID-19 Vaccine IP Waiver
By EsqSocial Corporation 11/05/21
On Friday, Dr. Albert Bourla, the Chairman and Chief Executive Officer of Pfizer, sent an open letter to Pfizer employees regarding the U.S. Trade Representative's announcement last week that the Biden-Harris Administration would support waiving intellectual property protections for COVID-19 vaccines. Dr. Bourla (at right) begins the letter by noting that the U.S. Trade Representative's announcement had "created some confusion" about whether Pfizer had "done enough to ensure fair and equitable...
By: McDonnell Boehnen Hulbert & Berghoff LLP